Search methodology
A thorough literature search (in October and November 2019) for studies comparing dHLD and sHLD for duodenoscopes was performed in the Web of Science, Scopus, PubMed, and Cochran databases. The search terms were “duodenoscope,” “ERCP endoscope,” “disinfection,” “sterilization,” and “reprocessing.”
Criteria of selected studies
Types of studies
Clinical trials in the English language that study dHLD were included.
The type of participant
Humans with a hepatobiliary indication for ERCP intervention were included.
The type of intervention
dHLD means 2 cycles of automated duodenoscope sterilization while sHLD means 1 cycle of standard high-level disinfection.
Study selection
Studies were independently evaluated by five authors (E.O., A.S., S.A., AL.A., and K.A.) who screened the title, the abstract, and then the full text, with articles being removed according to the exclusion criteria at each step, and this was done by the aid of Rayyan web. To ensure that all potentially relevant studies were considered for inclusion, further evaluation by a consensus of 4 authors (B.G., AB.A., AW.S., and K.F.) was performed.
Data extraction and risk of bias assessment
By 2 authors, the following data were extracted from each study: the first author, the year of publication, the study design, the number of participants, the type of intervention, the number of positive cultures, and the presence of drug-resistant organisms.
The risk of bias was conducted on RevMan 5 software.
Primary outcome
The primary outcome is culture-positive duodenoscopes after disinfection.
The percentage of the events were used to measure the treatment effect.
Statistical analysis
All analysis was conducted on RevMan 5 software.
A meta-analysis with 95% confidence interval (CI) was performed to measure risk difference in culture-positive duodenoscopes between dHLD and sHLD for included and eligible studies, and a random-effect model was applied.
Results
χ2 test was used to assess the presence of heterogeneity, while I2 test was used to assess the degree of heterogeneity.
A total of 1207 records were retrieved from databases based on search criteria (Fig. 1). After reviewing the title, abstracts, and full texts, 4 studies were found to be eligible for synthetic narrative analysis while only 2 were eligible for meta-analysis (Snyder et al. [10] and Bartles et al. [11]) as they compared dHLD against sHLD. A total of 6193 duodenoscope disinfection processes were found in the 4 studies. sHLD was presented in 2 studies (Snyder et al. [10] and Bartles et al. [11]) conducted 2972 times, while dHLD was presented in 4 studies done 3221 times.
Bang et al. [12] and Rex et al. [13] were single-arm studies evaluating dHLD. Snyder et al. [10] and Bartles et al. [11] (with the highest weight in our meta-analysis 98.6%) conducted a comparative clinical trial between dHLD and sHLD. So, this is presented in the risk of bias assessment in Fig 2.
There was no significant heterogeneity between the studies (χ2 = 0.7 and I2 = 0%) (Fig. 3).
The primary outcome is shown in Table 1 and Fig. 3.
Positive culture rate in sHLD was 4.7% while in dHLD was 4.9%, and there is no significant risk difference (RD) between both (p = 0.53, RD 0.003, 95% CI “− 0.007–0.013”).
Duodenoscope-related infections are of increasing global concern due to the emergence of multidrug-resistant bacteria such as carbapenem-resistant Enterobacteriaceae (CRE), with a bacterial biofilm production postulated as one cause of persistent infection from such virulent organisms [14]. The current standard for all flexible endoscope reprocessing includes pre-cleaning, leak testing, an additional manual cleaning step, and high-level disinfection [15]. Different disinfection alternative methods, over the standard one, were tried, such as N-acetylcysteine (NAC) [14], plasma-activated water (PAW) [16], and dHLD.
Our systematic review and meta-analysis tried to evaluate the efficacy of dHLD over sHLD, but we have been faced by a small number of trials on such topic. Snyder in his trial terminated the study after the follow-up period due to failure to reach the primary outcome of his study (multidrug-resistant organisms [MDRO]), but he concluded that dHLD did not decrease the culture-positive rate in duodenoscopes over sHLD. Bartles has conducted his study on both duodenoscopes and endoscopes and found that double HLD did not reduce culture positivity rates compared with single HLD in facilities with an already low positive culture rate.
All that was presented in our meta-analysis showed no statistically significant RD between dHLD and sHLD (p = 0.53, RD 0.003, 95% CI “− 0.007–0.013”).
